Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...
Q3 2025 Earnings Call October 30, 2025 1:00 PM EDTCompany ParticipantsMatthew GroverBenjamin Schall - President, CEO ...
Today's call will feature prepared comments by Will Lewis, Chair and Chief Executive Officer; Roger Adsett, Chief Operating Officer; and Sara Bonstein, Chief Financial Officer. After their comments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback